The seroconversion rate after 1 year of treatment ... famciclovir does not have a major role in the treatment of chronic hepatitis B because of its low efficacy compared with lamivudine.

The definition and clinical use of common HBV serological markers are shown in Table 2. HBsAg is the hallmark of HBV infection and is the first serological marker to appear in acute hepatitis B.

Hepatitis B, spread through bodily fluids ... oral NA therapy daily until meeting the criteria for stopping. HBsAg seroconversion remained 24 weeks after the end of treatment in 20% of those ...

13, 2024 (HealthDay News) -- For patients with chronic hepatitis B virus (HBV ... At 24 weeks after the end of treatment, HBsAg seroconversion occurred in 3, 0, 3, 20, and 0 percent of ...

Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...